We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
-0.2%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$147B
AUM Growth
+$7.72B
(+5.5%)
Cap. Flow
+$9.46B
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
41.95%
Holding
4,221
New
328
Increased
2,776
Reduced
891
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$888M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$700M |
| 3 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$408M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$338M |
| 5 |
Vanguard Russell 1000 Value ETF
VONV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$248M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$41.4M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$39.9M |
| 4 |
SCHV
Schwab US Large-Cap Value ETF
SCHV
|
+$34.6M |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.02% |
| 2 | Financials | 3.7% |
| 3 | Industrials | 2.22% |
| 4 | Healthcare | 2.17% |
| 5 | Consumer Discretionary | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Teva Pharmaceuticals
TEVA
$35.9B
| $1.96M | ﹤0.01% |
64,908
+2,072
| +3% | +$66.7K |
|
1902
Western Midstream Partners
WES
$19.7B
| $1.95M | ﹤0.01% |
47,353
+9,083
| +24% | +$376K |
|
1903
Crinetics Pharmaceuticals
CRNX
$8.87B
| $1.95M | ﹤0.01% |
53,637
+6,316
| +13% | +$282K |
|
1904
ProShares S&P 500 ex-Health Care ETF
SPXV
$38.8M
| $1.95M | ﹤0.01% |
27,425
| – | – |
|
1905
Coupang
CPNG
$27.9B
| $1.95M | ﹤0.01% |
103,146
+73,893
| +253% | +$1.45M |
|
1906
TriMas Corp
TRS
$1.43B
| $1.95M | ﹤0.01% |
54,160
+6,426
| +13% | +$231K |
|
1907
Riot Platforms
RIOT
$8.52B
| $1.94M | ﹤0.01% |
157,349
+37,753
| +32% | +$579K |
|
1908
Astronics
ATRO
$3.47B
| $1.94M | ﹤0.01% |
34,949
+3,036
| +10% | +$183K |
|
1909
Leggett & Platt
LEG
$1.53B
| $1.94M | ﹤0.01% |
196,289
-1,825
| -0.9% | -$20.8K |
|
1910
10x Genomics
TXG
$5.95B
| $1.94M | ﹤0.01% |
91,311
+32,592
| +56% | +$652K |
|
1911
Kohl's
KSS
$2.05B
| $1.94M | ﹤0.01% |
150,166
+47,970
| +47% | +$809K |
|
|
HAPN
1912
Happen Inc
HAPN
$2.09B
| $1.93M | ﹤0.01% |
134,987
+47,319
| +54% | +$793K |
|
1913
GDS Holdings
GDS
$6.34B
| $1.93M | ﹤0.01% |
47,900
-5,430
| -10% | -$233K |
|
1914
Alignment Healthcare
ALHC
$4.05B
| $1.93M | ﹤0.01% |
109,501
-1,045
| -0.9% | -$21K |
|
1915
Washington Trust Bancorp
WASH
$733M
| $1.93M | ﹤0.01% |
57,660
+4,898
| +9% | +$161K |
|
1916
iShares US Energy ETF
IYE
$1.74B
| $1.93M | ﹤0.01% |
29,743
+1,737
| +6% | +$98.5K |
|
1917
TFI International
TFII
$12.5B
| $1.93M | ﹤0.01% |
17,732
+2,157
| +14% | +$241K |
|
1918
Grab
GRAB
$13.6B
| $1.92M | ﹤0.01% |
525,663
+274,519
| +109% | +$1.16M |
|
1919
Chemours
CC
$2.59B
| $1.92M | ﹤0.01% |
87,292
+24,538
| +39% | +$427K |
|
1920
WisdomTree International Equity Fund
DWM
$666M
| $1.92M | ﹤0.01% |
27,454
-149
| -0.5% | -$10.7K |
|
1921
Great Southern Bancorp
GSBC
$866M
| $1.91M | ﹤0.01% |
30,307
+622
| +2% | +$38.9K |
|
1922
iShares US Financial Services ETF
IYG
$2.13B
| $1.91M | ﹤0.01% |
23,055
+224
| +1% | +$19.7K |
|
1923
Schwab 1-5 Year Corporate Bond ETF
SCHJ
$852M
| $1.91M | ﹤0.01% |
77,216
+24,916
| +48% | +$620K |
|
1924
Workiva
WK
$2.96B
| $1.91M | ﹤0.01% |
32,005
-438
| -1% | -$30.5K |
|
1925
Weatherford International
WFRD
$6.3B
| $1.91M | ﹤0.01% |
20,168
+1,930
| +11% | +$182K |
|
Similar funds
Creative Planning's Q1 2026 Portfolio in Review
As of Q1 2026, Creative Planning held 4,221 positions worth $147B, up 5.5% from $140B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $9.46B of net new capital in Q1 2026, opening 328 new positions and adding to 2,776 existing holdings. Its largest new stake was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 8.4% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $248M trimmed.
- Creative Planning's largest Q1 2026 buy was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
- Creative Planning added most to Vanguard Short-Term Bond ETF in Q1 2026, an estimated $888M increase.
- Creative Planning's biggest Q1 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $248M.
- Creative Planning fully exited CyberArk in Q1 2026, selling an estimated $9.29M.
- Creative Planning's ten largest holdings make up 42% of its $147B portfolio in Q1 2026.
- Creative Planning opened 328 new positions and closed 131 in Q1 2026.
- Creative Planning's portfolio value rose 5.5% quarter-over-quarter to $147B.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.